ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Zhaofan Luo
Matched on ORCID iD 0000-0002-4874-7993; OpenAlex author ID A5100845264. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 4
- Defining homologous recombination deficiency status in pancreatic ductal adenocarcinoma: Clinical implications for evaluating response to platinum chemotherapy. Co-author DOI 10.1016/j.drup.2025.101291↗
- HNF1A inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1. Co-author DOI 10.1016/j.ebiom.2019.05.013↗
- Effect of NR5A2 inhibition on pancreatic cancer stem cell (CSC) properties and epithelial-mesenchymal transition (EMT) markers. Co-author DOI 10.1002/mc.22604↗
- Hepatocyte nuclear factor 1A (HNF1A) as a possible tumor suppressor in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0121082↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zunfu Ke · 1 shared paper, 2025 · strength 0.23
- Yanxia Wang · 1 shared paper, 2025 · strength 0.23
- Huamin Wang · 2 shared papers, 2015–2017 · strength 0.13
- Donghui Li · 2 shared papers, 2015–2017 · strength 0.13
- Yanan Lu · 1 shared paper, 2019 · strength 0.09
- Zhi Wang · 1 shared paper, 2019 · strength 0.09
- Huimou Chen · 1 shared paper, 2019 · strength 0.09
- Dongni Xu · 1 shared paper, 2019 · strength 0.09
- Ya’an Kang · 1 shared paper, 2015 · strength 0.05
- Jason B. Fleming · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.